IRIS
LO CAPUTO, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.691
EU - Europa 3.821
AS - Asia 3.289
SA - Sud America 1.003
Continente sconosciuto - Info sul continente non disponibili 733
AF - Africa 104
OC - Oceania 4
Totale 14.645
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.495
SG - Singapore 1.559
IE - Irlanda 1.007
RU - Federazione Russa 958
BR - Brasile 840
HK - Hong Kong 518
CN - Cina 506
IT - Italia 409
VN - Vietnam 304
DE - Germania 303
SE - Svezia 295
FR - Francia 262
UA - Ucraina 129
FI - Finlandia 119
GB - Regno Unito 116
BD - Bangladesh 68
CA - Canada 66
AR - Argentina 57
IN - India 50
AT - Austria 49
MX - Messico 49
IQ - Iraq 48
NL - Olanda 42
TR - Turchia 38
ES - Italia 33
ID - Indonesia 29
ZA - Sudafrica 29
VE - Venezuela 25
JP - Giappone 22
EC - Ecuador 21
PK - Pakistan 19
CZ - Repubblica Ceca 18
UZ - Uzbekistan 18
PL - Polonia 17
BE - Belgio 15
CO - Colombia 14
KE - Kenya 13
PH - Filippine 13
PY - Paraguay 13
CL - Cile 12
JM - Giamaica 12
LT - Lituania 12
SA - Arabia Saudita 12
CR - Costa Rica 11
NP - Nepal 11
PE - Perù 11
AZ - Azerbaigian 10
MA - Marocco 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
TT - Trinidad e Tobago 9
IR - Iran 8
SV - El Salvador 8
EG - Egitto 7
HN - Honduras 7
NI - Nicaragua 7
CW - ???statistics.table.value.countryCode.CW??? 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
JO - Giordania 6
MY - Malesia 6
BO - Bolivia 5
GT - Guatemala 5
NG - Nigeria 5
PR - Porto Rico 5
QA - Qatar 5
HU - Ungheria 4
KZ - Kazakistan 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
AU - Australia 3
BB - Barbados 3
CI - Costa d'Avorio 3
EE - Estonia 3
KR - Corea 3
RO - Romania 3
BF - Burkina Faso 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
GP - Guadalupe 2
KH - Cambogia 2
KW - Kuwait 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
NO - Norvegia 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TL - Timor Orientale 2
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CG - Congo 1
DK - Danimarca 1
Totale 13.900
Salva come PNG Salva come JPEG
Città #
San Jose 1.572
Dublin 1.005
Singapore 622
Ashburn 551
Hong Kong 514
Santa Clara 275
Council Bluffs 244
Columbus 228
Dallas 211
Nyköping 208
Lauterbourg 196
Beijing 194
Chandler 165
Munich 162
Moscow 141
Princeton 121
Los Angeles 108
Ho Chi Minh City 95
Helsinki 93
New York 86
Wilmington 75
São Paulo 66
Phoenix 55
Hanoi 50
The Dalles 42
Bari 41
Frankfurt am Main 39
Nuremberg 39
North Bergen 38
Des Moines 34
Dong Ket 34
Rio de Janeiro 33
Assago 32
Hudson 30
London 27
Brooklyn 25
San Francisco 25
Boardman 24
Dearborn 24
Jacksonville 23
Tokyo 22
Atlanta 21
Orem 20
Baghdad 19
Brasília 19
Vienna 19
Boston 18
Shanghai 18
Düsseldorf 17
Johannesburg 17
Nanjing 17
Belo Horizonte 16
Chennai 16
Da Nang 16
Falkenstein 16
Warsaw 16
Washington 16
Montreal 15
Stockholm 15
Tashkent 15
Gioia Del Colle 14
Brussels 13
Chicago 13
Milan 13
Seattle 13
Toronto 13
Campinas 12
St Louis 12
Turku 12
Brno 11
Curitiba 11
Denver 11
Guangzhou 11
Istanbul 11
Nairobi 11
Palermo 11
Rome 11
Norwalk 10
Salvador 10
Amsterdam 9
Baku 9
Buffalo 9
Erbil 9
Maceió 9
Porto Alegre 9
Wuhan 9
Caracas 8
Cincinnati 8
Goiânia 8
Guayaquil 8
Kingston 8
Mexico City 8
San José 8
San Salvador 8
Ankara 7
Canoas 7
Caxias do Sul 7
Foggia 7
Hillsboro 7
Joinville 7
Totale 8.287
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 243
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 209
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study 140
Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2? 131
Tocilizumab and corticosteroids for covid-19 treatment in elderly patients. Journal of Gerontology and Geriatrics 130
Efficacy and Safety of Remdesivir over Two Waves of the Sars-CoV-2 Pandemic 129
Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy. 121
2Apolipoprotein B mRNA–Editing Enzyme, Catalytic Polypeptide–Like 3G: A PossibleRole in the Resistance to HIV of HIV-1 Exposed Seronegative Individuals 113
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study 110
Percorsi di vaccinazione anti-Herpes Zoster nel paziente fragile: proposte dagli specialisti del Policlinico Foggia 109
Monitoraggio virologico in soggetti con infezione da HIV in trattamento con Zidovudina (AZT) 106
Prevalence of hepatitis virus infections in Albanian refugees. 103
Long-term failure of antiviral activity of Zidovudine therapy in anti-HIV positive subjects 103
Sex and gender differences in COVID-19: an Italian local register- based study 103
Monkeypox virus infection mimicking primary syphilis 99
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): Data from a real-life setting 98
Baricitinib: A chance to treat COVID-19? 97
Two nasal swabs may not be enough to exclude SARS-CoV-2 infection in symptomatic patients 97
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 96
Safety and heart rate changes in Covid-19 patients treated with Remdesivir 96
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 93
Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic 92
Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection 91
. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 91
Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users 91
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience 90
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 90
A positively selected APOBEC3H haplotype is associated with natural resistance to HIV-1 infection 89
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 89
A comprehensive development agenda on tenofovir alafenamide in clinical practice 89
Assessing ChatGPT's Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 88
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients 87
Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals 87
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 87
A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infection 87
Lost to follow-up: a challenge over 10 years 87
Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy 85
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort 85
IL-22 Participates in an Innate Anti-HIV-1 Host-Resistance Network through Acute-Phase Protein Induction 85
Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection 85
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment 84
Comparison between Rules-Based Human Immunodeficiency Virus Type 1 Genotype Interpretations and Real or Virtual Phenotype: Concordance Analysis and Correlation with Clinical Outcome in Heavily Treated Patients 82
Influence of Gender, Age, and Transmission Category on the Progression From HIV Seroconversion to AIDS 82
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 82
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection 81
Twenty Years Later: the Recent Trends of HIV-infection – Evidence from an Italian Region 80
Prevalence and genetic diversity of Blastocystis sp. among autochthonous and immigrant patients in Italy 79
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev 79
Resistance to Dideoxynucleoside Reverse Transcriptase Inhibitors: Genotypic-Phenotypic Correlations 79
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 78
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 78
A role for mucosal immunity in resistance to HIV infection 77
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy 77
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study 76
Pregnancy Outcomes Among ART-Naive and ART-Experienced HIV-Positive Women: Data From the ICONA Foundation Study Group, Years 1997–2013 76
A Randomized Controlled Trial to Evaluate Antiretroviral Salvage Therapy Guided by Rules-Based or Phenotype-Driven HIV-1 Genotypic Drug-Resistance Interpretation With or Without Concentration-Controlled Intervention: The Resistance and Dosage Adapted Regimens (RADAR) Study 76
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia. 76
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients - evidence from a large observational cohort 76
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 75
A Comprehensive Development Agenda on Tenofovir Alafenamide in Clinical Practice 75
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 75
Incidence and factors associated with the risk of sexually transmitted diseases in HIV‐infected people seen for care in Italy: data from the Icona Foundation cohort 75
. Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 75
Disparities in tuberculosis diagnostic delays between native and migrant populations in Italy: A multicenter study 75
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 74
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey 74
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy 74
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection 74
Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV 73
Evaluation of the effect of protective genetic variants on cart success in hiv-1-infected patients 73
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 73
HIV rapid test in a community setting as a strategy to improve access to HIV testing: Data from a multicentre experience in Italy 73
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy 73
Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients 72
Neuropsychiatric Disorders in Pediatric Long COVID-19: A Case Series 71
Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia 71
Successful Treatment of Aortic Endocarditis by Achromobacter xylosoxidans with Cefiderocol Combination Therapy in a Non-Hodgkin Lymphoma Patient: Case Report and Literature Review 71
Severity of covid‐19 patients predicted by serum sphingolipids signature 71
Doravirine Plus Integrase Strand Transfer Inhibitors as a 2-Drug Treatment–Switch Strategy in People Living with HIV: The Real-Life DORINI Multicentric Cohort Study 70
Prevalence and genetic diversity of Blastocystis sp. among autochthonous and immigrant patients in Italy 70
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 70
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 69
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort 69
Enhancing care for people living with HIV: current and future monitoring approaches 69
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 69
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 68
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 68
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study 68
Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission 68
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 68
Clinical Characteristics, Outcomes, and Risk Factors of Patients Hospitalized for COVID-19 across the Latest Pandemic Waves: Has Something Changed? 67
The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection 67
RADAR Study Group of MASTER Cohort “Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients 67
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 67
An evolutionary analysis of antigen processing and presentation across different timescales reveals pervasive selection. 66
Impact of vaccination on electrocardiograms of hospitalized patients for Covid-19 65
Increased risk of virological failure to the first antiretroviral regimen in HIV‐infected migrants compared to natives: data from the ICONA cohort 65
Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees 64
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts 64
Influence of Genotype 3 Hepatitis C Coinfection on Liver Enzyme Elevation in HIV-1-Positive Patients After Commencement of a New Highly Active Antiretroviral Regimen: Results From the EPOKA-MASTER Cohort 64
Totale 8.568
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022405 0 0 0 15 30 26 12 50 63 36 24 149
2022/20231.805 164 27 90 36 35 117 12 62 1.116 94 28 24
2023/2024558 68 34 28 16 30 96 65 12 108 21 9 71
2024/20253.546 196 64 69 66 64 390 669 218 1.013 188 252 357
2025/20265.828 334 430 670 872 280 241 1.365 624 346 411 138 117
2026/20271.819 95 534 489 701 0 0 0 0 0 0 0 0
Totale 14.645